Active substance
Fat emulsions
- SFDA 10
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| INTRALIPID 10% (SOYBEAN OIL) | 10 % | Infusion · Parenteral use | 1 Bottle | SAR 67.60 | Generic · Prescription | OCTAPHARMA | Withdrawn by MAH · Not Marketed |
| INTRALIPID 10% (SOYBEAN OIL) | 10 % | Infusion · Parenteral use | 1 Bottle | SAR 15.40 | Generic · Prescription | OCTAPHARMA | Withdrawn by MAH · Not Marketed |
| INTRALIPID 20% (SOYBEAN OIL) | 20 % | Infusion · Parenteral use | 1 Bottle | SAR 104.75 | Generic · Prescription | OCTAPHARMA | Withdrawn by MAH · Not Marketed |
| INTRALIPID 20% (SOYBEAN OIL) | 20 % | Infusion · Parenteral use | 1 Bottle | SAR 35.65 | Generic · Prescription | OCTAPHARMA | Withdrawn by MAH · Not Marketed |
| LIPOSYN 10% (SAFFLOWER OIL) | 10 % | Infusion · Parenteral use | 1 Bottle | SAR 13.10 | Generic · Prescription | HOSPIRA INC | Withdrawn by MAH · Not Marketed |
| LIPOSYN II 20% (SOYABEEN OIL) | 20 % | Solution · Parenteral use | 1 Bottle | SAR 94.85 | Generic · Prescription | HOSPIRA INC | Withdrawn by MAH · Not Marketed |
| LIPOSYN II 20% (SOYABEEN OIL) | 20 % | Infusion · Parenteral use | 1 Bottle | SAR 45.55 | Generic · Prescription | HOSPIRA INC | Withdrawn by MAH · Not Marketed |
| LIPOSYN II 20% (SOYABEEN OIL) | 20 % | Infusion · Parenteral use | 1 Bottle | SAR 45.55 | Generic · Prescription | Abbott Laboratories | Invalid · Not Marketed |
| LIPOVENOS 10% (SOYBEAN OIL) | 10 % | Infusion · Parenteral use | 1 Bottle | SAR 60.00 | Generic · Prescription | FRESENIUS KABI | Withdrawn by MAH · Not Marketed |
| LIPOVENOS 20% (SOYBEAN OIL) | 20 % | Infusion · Parenteral use | 1 Bottle | SAR 64.60 | Generic · Prescription | FRESENIUS KABI | Withdrawn by MAH · Not Marketed |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.